share_log

四環醫藥：建議發行股份及購回股份的一般授權、重選退任董事及股東週年大會通告

SIHUAN PHARM: PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING

Hong Kong Stock Exchange ·  Apr 26 04:38
Summary by Moomoo AI
四環醫藥控股集團有限公司（「四環醫藥」）將於2024年6月7日舉行股東週年大會，地點為中國深圳市福田區的深圳大中華希爾頓酒店。會議將討論及投票決定包括發行及購回股份的一般授權、重選退任董事等事項。四環醫藥建議授予董事發行股份的一般授權，最多可發行相當於已發行股份總數20%的額外股份，以及購回不超過已發行股份總數10%的股份。股東週年大會通告及相關的代表委任表格已於公司網站及香港聯合交易所有限公司網站公布。四環醫藥亦將於2024年6月3日至7日暫停股份過戶登記，以確定股東出席大會及投票的權利。此外，董事會建議股東批准重選車馮升醫生為執行董事，以及曾華光先生和朱迅博士為獨立非執行董事。
四環醫藥控股集團有限公司（「四環醫藥」）將於2024年6月7日舉行股東週年大會，地點為中國深圳市福田區的深圳大中華希爾頓酒店。會議將討論及投票決定包括發行及購回股份的一般授權、重選退任董事等事項。四環醫藥建議授予董事發行股份的一般授權，最多可發行相當於已發行股份總數20%的額外股份，以及購回不超過已發行股份總數10%的股份。股東週年大會通告及相關的代表委任表格已於公司網站及香港聯合交易所有限公司網站公布。四環醫藥亦將於2024年6月3日至7日暫停股份過戶登記，以確定股東出席大會及投票的權利。此外，董事會建議股東批准重選車馮升醫生為執行董事，以及曾華光先生和朱迅博士為獨立非執行董事。
Four Ring Pharmaceutical Holdings Group Co., Ltd. (“Four Ring Pharmaceuticals”) will hold its Annual General Meeting on June 7, 2024 at the Hilton Shenzhen Grand China in Futian District, Shenzhen, China. The meeting will discuss and vote on matters including general mandates to issue and repurchase shares, re-election of retiring directors, etc. Quadruple Pharmaceuticals proposes to grant the directors a general mandate to issue shares, to issue up to 20% of the total issued shares and to repurchase shares not exceeding 10% of the total issued shares. The Notice of the Annual General Meeting and the related proxy form have been published on the Company's website and on the website of the United Stock Exchange Limited. Fourcircle Pharmaceuticals will also suspend the...Show More
Four Ring Pharmaceutical Holdings Group Co., Ltd. (“Four Ring Pharmaceuticals”) will hold its Annual General Meeting on June 7, 2024 at the Hilton Shenzhen Grand China in Futian District, Shenzhen, China. The meeting will discuss and vote on matters including general mandates to issue and repurchase shares, re-election of retiring directors, etc. Quadruple Pharmaceuticals proposes to grant the directors a general mandate to issue shares, to issue up to 20% of the total issued shares and to repurchase shares not exceeding 10% of the total issued shares. The Notice of the Annual General Meeting and the related proxy form have been published on the Company's website and on the website of the United Stock Exchange Limited. Fourcircle Pharmaceuticals will also suspend the registration of shares from 3 to 7 June 2024 in order to determine the right of shareholders to attend general meetings and vote. In addition, the Board of Directors proposes that shareholders approve the re-election of Dr. Che Feng Sheng as Executive Director and Mr. Tsang Huakwang and Dr. Zhu Xun as independent non-executive directors.

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more